메뉴 건너뛰기




Volumn 29, Issue 2, 2012, Pages 218-224

Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors

Author keywords

Conditionally replication adenovirus; Drug interaction; Histone deacetylase inhibitor; p21

Indexed keywords

CONDITIONALLY REPLICATING ADENOVIRUS; DELTA24; HISTONE DEACETYLASE INHIBITOR; LUCIFERASE; PROTEIN P21; SBHA; SK 7041; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VORINOSTAT;

EID: 84855182767     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.831     Document Type: Article
Times cited : (15)

References (23)
  • 1
    • 0030917202 scopus 로고    scopus 로고
    • ONYX-015, an E1b gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
    • DOI 10.1038/nm0697-639
    • Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD and Kirn DH: ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med 3: 639-645, 1997. (Pubitemid 27264973)
    • (1997) Nature Medicine , vol.3 , Issue.6 , pp. 639-645
    • Heise, C.1    Sampson-Johannes, A.2    Williams, A.3    McCormick, F.4    Von Hoff, D.D.5    Kirn, D.H.6
  • 2
    • 0033782862 scopus 로고    scopus 로고
    • An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
    • Heise C, Hermiston T, Johnson L, et al.: An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat Med 6: 1134-1139, 2000.
    • (2000) Nat Med , vol.6 , pp. 1134-1139
    • Heise, C.1    Hermiston, T.2    Johnson, L.3
  • 4
    • 0042674013 scopus 로고    scopus 로고
    • Telomerase-dependent oncolytic adenovirus for cancer treatment
    • DOI 10.1038/sj.gt.3301987
    • Huang TG, Savontaus MJ, Shinozaki K, Sauter BV and Woo SL: Telomerase-dependent oncolytic adenovirus for cancer treatment. Gene Ther 10: 1241-1247, 2003. (Pubitemid 36934726)
    • (2003) Gene Therapy , vol.10 , Issue.15 , pp. 1241-1247
    • Huang, T.-G.1    Savontaus, M.J.2    Shinozaki, K.3    Sauter, B.V.4    Woo, S.L.C.5
  • 5
    • 76349110981 scopus 로고    scopus 로고
    • Current issues and future directions of oncolytic adenoviruses
    • Yamamoto M and Curiel DT: Current issues and future directions of oncolytic adenoviruses. Mol Ther 18: 243-250, 2010.
    • (2010) Mol Ther , vol.18 , pp. 243-250
    • Yamamoto, M.1    Curiel, D.T.2
  • 6
    • 0035138484 scopus 로고    scopus 로고
    • Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate
    • Lee CT, Seol JY, Park KH, et al.: Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate. Clin Cancer Res 7: 210-214, 2001.
    • (2001) Clin Cancer Res , vol.7 , pp. 210-214
    • Lee, C.T.1    Seol, J.Y.2    Park, K.H.3
  • 8
    • 0242610345 scopus 로고    scopus 로고
    • The Histone Deacetylase Inhibitor FK228 Preferentially Enhances Adenovirus Transgene Expression in Malignant Cells
    • Goldsmith ME, Kitazono M, Fok P, Aikou T, Bates S and Fojo T: The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells. Clin Cancer Res 9: 5394-5401, 2003. (Pubitemid 37413595)
    • (2003) Clinical Cancer Research , vol.9 , Issue.14 , pp. 5394-5401
    • Goldsmith, M.E.1    Kitazono, M.2    Fok, P.3    Aikou, T.4    Bates, S.5    Fojo, T.6
  • 9
    • 0035418558 scopus 로고    scopus 로고
    • Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228
    • Kitazono M, Goldsmith ME, Aikou T, Bates S and Fojo T: Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res 61: 6328-6330, 2001. (Pubitemid 32783231)
    • (2001) Cancer Research , vol.61 , Issue.17 , pp. 6328-6330
    • Kitazono, M.1    Goldsmith, M.E.2    Aikou, T.3    Bates, S.4    Fojo, T.5
  • 10
    • 33847302895 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity
    • VanOosten RL, Earel JK Jr, and Griffith TS: Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity. Apoptosis 12: 561-571, 2007.
    • (2007) Apoptosis , vol.12 , pp. 561-571
    • VanOosten, R.L.1    Earel Jr., J.K.2    Griffith, T.S.3
  • 11
    • 0030984807 scopus 로고    scopus 로고
    • Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase
    • DOI 10.1006/viro.1997.8538
    • Dion LD, Goldsmith KT, Tang DC, Engler JA, Yoshida M and Garver RI Jr: Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. Virology 231: 201-209, 1997. (Pubitemid 27244186)
    • (1997) Virology , vol.231 , Issue.2 , pp. 201-209
    • Dion, L.D.1    Goldsmith, K.T.2    Tang, D.-C.3    Engler, J.A.4    Yoshida, M.5    Garver Jr., R.I.6
  • 12
    • 79959380355 scopus 로고    scopus 로고
    • Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells
    • Kim DR, Park MY, Lee CS, et al.: Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells. Cancer Gene Ther 18: 467-477, 2011.
    • (2011) Cancer Gene Ther , vol.18 , pp. 467-477
    • Kim, D.R.1    Park, M.Y.2    Lee, C.S.3
  • 13
    • 77953544825 scopus 로고    scopus 로고
    • Oncolytic viruses and histone deacetylase inhibitors - A multi-pronged strategy to target tumor cells
    • Nguyen TL, Wilson MG and Hiscott J: Oncolytic viruses and histone deacetylase inhibitors - a multi-pronged strategy to target tumor cells. Cytokine Growth Factor Rev 21: 153-159, 2010.
    • (2010) Cytokine Growth Factor Rev , vol.21 , pp. 153-159
    • Nguyen, T.L.1    Wilson, M.G.2    Hiscott, J.3
  • 14
    • 33751248498 scopus 로고    scopus 로고
    • Valproic Acid, a Histone Deacetylase Inhibitor, Is an Antagonist for Oncolytic Adenoviral Gene Therapy
    • DOI 10.1016/j.ymthe.2006.07.009, PII S1525001606014869
    • Hoti N, Chowdhury W, Hsieh JT, Sachs MD, Lupold SE and Rodriguez R: Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy. Mol Ther 14: 768-778, 2006. (Pubitemid 44780612)
    • (2006) Molecular Therapy , vol.14 , Issue.6 , pp. 768-778
    • Hoti, N.1    Chowdhury, W.2    Hsieh, J.-T.3    Sachs, M.D.4    Lupold, S.E.5    Rodriguez, R.6
  • 15
    • 70350118707 scopus 로고    scopus 로고
    • RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses
    • Shiina M, Lacher MD, Christian C and Korn WM: RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses. Cancer Gene Ther 16: 810-819, 2009.
    • (2009) Cancer Gene Ther , vol.16 , pp. 810-819
    • Shiina, M.1    Lacher, M.D.2    Christian, C.3    Korn, W.M.4
  • 16
    • 77954816343 scopus 로고    scopus 로고
    • Armoring CRAds with p21/Waf-1 shRNAs: The next generation of oncolytic adenoviruses
    • Hoti N, Chowdhury WH, Mustafa S, et al.: Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses. Cancer Gene Ther 17: 585-597, 2010.
    • (2010) Cancer Gene Ther , vol.17 , pp. 585-597
    • Hoti, N.1    Chowdhury, W.H.2    Mustafa, S.3
  • 18
    • 30744452281 scopus 로고    scopus 로고
    • Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: Histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520
    • DOI 10.1089/hum.2006.17.55
    • Bieler A, Mantwill K, Dravits T, et al.: Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520. Hum Gene Ther 17: 55-70, 2006. (Pubitemid 43100515)
    • (2006) Human Gene Therapy , vol.17 , Issue.1 , pp. 55-70
    • Bieler, A.1    Mantwill, K.2    Dravits, T.3    Bernshausen, A.4    Glockzin, G.5    Kohler-Vargas, N.6    Lage, H.7    Gansbacher, B.8    Holm, P.S.9
  • 19
    • 54449089024 scopus 로고    scopus 로고
    • Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
    • Nguyen TL, Abdelbary H, Arguello M, et al.: Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proc Natl Acad Sci USA 105: 14981-14986, 2008.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 14981-14986
    • Nguyen, T.L.1    Abdelbary, H.2    Arguello, M.3
  • 20
    • 77954882437 scopus 로고    scopus 로고
    • P21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
    • Flak MB, Connell CM, Chelala C, et al.: p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker. Mol Cancer 9: 175, 2010.
    • (2010) Mol Cancer , vol.9 , pp. 175
    • Flak, M.B.1    Connell, C.M.2    Chelala, C.3
  • 22
    • 77955519631 scopus 로고    scopus 로고
    • Oncolytic-adenovirus-expressed RNA interference for cancer therapy
    • Pei DS, Di JH, Chen FF and Zheng JN: Oncolytic-adenovirus-expressed RNA interference for cancer therapy. Expert Opin Biol Ther 10: 1331-1341, 2010.
    • (2010) Expert Opin Biol Ther , vol.10 , pp. 1331-1341
    • Pei, D.S.1    Di, J.H.2    Chen, F.F.3    Zheng, J.N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.